Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3810156
Max Phase: Preclinical
Molecular Formula: C51H78N14O11S2
Molecular Weight: 1127.41
Molecule Type: Protein
Associated Items:
ID: ALA3810156
Max Phase: Preclinical
Molecular Formula: C51H78N14O11S2
Molecular Weight: 1127.41
Molecule Type: Protein
Associated Items:
Canonical SMILES: CSCC[C@H](NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
Standard InChI: InChI=1S/C51H78N14O11S2/c1-29(2)22-37(47(72)60-35(17-9-10-19-52)45(70)65-41(28-77)49(74)64-39(50(75)76)23-30-12-5-4-6-13-30)63-46(71)36(18-21-78-3)61-48(73)40(27-66)59-42(67)26-58-44(69)38(24-31-25-57-34-16-8-7-14-32(31)34)62-43(68)33(53)15-11-20-56-51(54)55/h4-8,12-14,16,25,29,33,35-41,57,66,77H,9-11,15,17-24,26-28,52-53H2,1-3H3,(H,58,69)(H,59,67)(H,60,72)(H,61,73)(H,62,68)(H,63,71)(H,64,74)(H,65,70)(H,75,76)(H4,54,55,56)/t33-,35-,36-,37-,38-,39-,40-,41-/m0/s1
Standard InChI Key: DYRXNBDGJUKSDL-UMFIYRSOSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Protein | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1127.41 | Molecular Weight (Monoisotopic): 1126.5416 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Gilliam AJ, Smith JN, Flather D, Johnston KM, Gansmiller AM, Fishman DA, Edgar JM, Balk M, Majumdar S, Weiss GA.. (2016) Affinity-Guided Design of Caveolin-1 Ligands for Deoligomerization., 59 (8): [PMID:27010220] [10.1021/acs.jmedchem.5b01536] |
Source(1):